title: Is interferon-a an active agent in Castleman's disease?
authors.affiliation: Department of Medicine, University of Ioannina, Greece.
authors.forename: N A
authors.initials: NA
authors.lastname: Pavlidis
authors.forename: E
authors.initials: E
authors.lastname: Briassoulis
authors.forename: G
authors.initials: G
authors.lastname: Klouvas
authors.forename: M
authors.initials: M
authors.lastname: Bai
mesh_terms: D005871:Castleman Disease / Q000628:therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins